📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
HIGH
score: 0.50
SENTIMENT
BEARISH
TOTAL VIEWS
2
MGNX Latest News & AI Sentiment Analysis
2 articles · Grade: HIGH · Real-time AI-graded coverage
RECENT COVERAGE · 3 ARTICLES
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
MacroGenics (MGNX) has divested its GMP manufacturing operations to Bora Pharmaceuticals (BORAY), a strategic asset sale that reflects a...
MacroGenics: 'Hold' Potential Best-In-Class B7-H3 ADC And TZIELD Payment (NASDAQ:MGNX)
MacroGenics (MGNX) received a downgrade to Hold rating, primarily driven by setbacks in its B7-H3 antibody-drug conjugate (ADC) program....
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
MacroGenics (MGNX) secured a $24.5 million regulatory milestone payment from Sanofi following FDA accelerated approval of TZIELD® for...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice